Genetic Therapies, Wearable Devices, and AI Technologies to be Aware of in 2023: Anup Patel, MD


The pediatric neurologist at Nationwide Children's Hospital spoke on several innovations and potential concerns in neurology clinicians should expect in 2023. [WATCH TIME: 6 minutes]

WATCH TIME: 6 minutes

“I'm excited about using and utilizing existing technologies such as the Apple Watch, or the Fitbit, or some of these devices used across the world, and seeing what benefits and opportunities exist there.”

Looking ahead, there are several promising treatments in the pipeline for patients with epilepsy. Genetic therapies, which are currently in development, have potential to reduce seizure frequency and be an alternate, more effective treatment option for patients with epilepsy if newer antiseizure medications fail. Another advancement for preventing seizures may involve the use of mobile or wearable devices, thus allowing clinicians to track the progress of their patients.

Besides genetic therapies and wearable devices for preventive seizure care, another strategy that has gained momentum is incorporating artificial intelligence (AI) technology. Using machine learning algorithm systems such as AI has become more of a popular tool, not just in epilepsy, but across all of neurology. Anup Patel, MD, pediatric neurologist at Nationwide Children's Hospital, sat down with NeurologyLive® in an interview to discuss the several exciting technologies clinicians should be aware of in 2023 to treat patients with epilepsy. Patel, professor of clinical pediatrics and neurology at Nationwide Children's Hospital and at the Ohio State University College of Medicine, talked about new treatment options, wearable devices, and predictive algorithms to enter in clinical practice in the coming year.

Related Videos
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.